Public trial registry of the CCC-Munich

Trial SORATRAM

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
SORATRAM
World
Full title
:

Cross-institutional, prospective, open label, single group basket study of combined CRAF and MEK inhibition in advanced-stage malignancies harboring BRAF mutations with impaired kinase activity

World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Other tumors
Trial design
World
Phase
:
I
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Positive
World
Institutional review board - vote date
:
2020-06-25
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Zielgerichtet

Participants
Function Prename Surname Organization
World Responsible contact Simon Heidegger 3. Med 3. Med Ismaninger Str. 22 81675 München Germany Magnifier